1-2 of 2
J.L. Guzmán
Close
Sort by
Journal Articles

Multicenter, Randomized, Open-Label, Phase III Trial of Lenalidomide-Dexamethasone (Len/dex) Vs Therapeutic Abstention in Smoldering Multiple Myeloma at High Risk of Progression to Symptomatic MM: Results of the First Interim Analysis.

Maria-Victoria Mateos, MD, PhD, Lucía López-Corral, Miguel T Hernández, Javier de la Rubia, Juan José Lahuerta, MD, PhD, Pilar Giraldo, MD, Joan Bargay, MD, Laura Rosiñol, Albert Oriol, MD, Jose García-Laraña, Luis Palomera, Felipe de Arriba, Felipe Prosper, MD, Mariluz Martino, MD, Ana-Isabel Teruel, José Hernández, Graça Esteves, Mario Mariz, Adrian Alegre, MD, J.L. Guzmán, Nuria Quintana, Jose-Luis Garcia, Jesús F. San-Miguel, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 614.
https://doi.org/10.1182/blood.V114.22.614.614
Published: 2009
Journal Articles

Efficacy of Lenalidomide in Different Clinical Settings in Patients with Relapsed or Progressive Multiple Myeloma: Updated Analysis of 111 Cases of the Spanish Compassionate Use Program

A. Alegre, B. Aguado, P. Giraldo, P. Cánovas, A. Ibáñez, I. Castillo, M. Blanes, E. Ríos, J.N. Rodríguez, L. Palomera, MT Hernández, A. Oriol, E. Sancho, C. Menchaca, J. Vercher, AP González, M.J. Arilla, G. Ramírez, R. Pérez, A. Asensio, Javier De la Serna, MD, S. Osorio, C. Aguilar, V. Ansó, J.M. Calvo, M. Casanova, M. Fuertes, J.L. Guzmán, L. López, A. López, J.L. Olalla, J.M Hernández, P. Ríos, L. Villalon, I. García, A. García, S. Larregla, F. Lara, J.L. Lahuerta
Journal: Blood
Blood (2008) 112 (11): 5199.
https://doi.org/10.1182/blood.V112.11.5199.5199
Published: 2008